

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of isotype switching to IgG isotypes (GO:0048302) | 9.76913618 |
| 2 | activated T cell proliferation (GO:0050798) | 9.68401160 |
| 3 | lens fiber cell development (GO:0070307) | 9.07701812 |
| 4 | positive regulation of isotype switching (GO:0045830) | 7.65420743 |
| 5 | positive regulation of DNA recombination (GO:0045911) | 6.63332590 |
| 6 | interferon-gamma production (GO:0032609) | 6.19945654 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.63581088 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.63581088 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.45093574 |
| 10 | positive regulation of B cell mediated immunity (GO:0002714) | 5.40557425 |
| 11 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.40557425 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.27912966 |
| 13 | regulation of NFAT protein import into nucleus (GO:0051532) | 5.18690894 |
| 14 | dopamine transport (GO:0015872) | 5.14540342 |
| 15 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 5.12524017 |
| 16 | UMP biosynthetic process (GO:0006222) | 5.12524017 |
| 17 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 5.12524017 |
| 18 | UMP metabolic process (GO:0046049) | 5.12524017 |
| 19 | leukotriene biosynthetic process (GO:0019370) | 5.05112672 |
| 20 | regulation of isotype switching (GO:0045191) | 4.95798029 |
| 21 | toxin transport (GO:1901998) | 4.95700508 |
| 22 | histamine transport (GO:0051608) | 4.93645688 |
| 23 | lymphocyte migration (GO:0072676) | 4.78620443 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.75988369 |
| 25 | mast cell activation involved in immune response (GO:0002279) | 4.75835307 |
| 26 | mast cell degranulation (GO:0043303) | 4.75835307 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 4.73375727 |
| 28 | positive regulation of immunoglobulin production (GO:0002639) | 4.72899275 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.70679624 |
| 30 | leukocyte aggregation (GO:0070486) | 4.53381703 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.45209366 |
| 32 | response to interleukin-15 (GO:0070672) | 4.24645996 |
| 33 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 4.23341554 |
| 34 | nucleobase biosynthetic process (GO:0046112) | 4.21800401 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 4.21096675 |
| 36 | mast cell activation (GO:0045576) | 4.09592865 |
| 37 | positive regulation of T cell cytokine production (GO:0002726) | 4.07531250 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.03257818 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.98554142 |
| 40 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.96842355 |
| 41 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.94051373 |
| 42 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.94051373 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91555141 |
| 44 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.90763517 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.87532197 |
| 46 | cellular response to exogenous dsRNA (GO:0071360) | 3.86330201 |
| 47 | microglial cell activation (GO:0001774) | 3.83315948 |
| 48 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.82862304 |
| 49 | leukotriene metabolic process (GO:0006691) | 3.78617199 |
| 50 | regulation of B cell mediated immunity (GO:0002712) | 3.77838696 |
| 51 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.76930044 |
| 52 | leukocyte degranulation (GO:0043299) | 3.72473194 |
| 53 | peripheral nervous system neuron development (GO:0048935) | 3.67557699 |
| 54 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.64316565 |
| 55 | cytolysis (GO:0019835) | 3.61482593 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 3.60758344 |
| 57 | cellular response to interferon-beta (GO:0035458) | 3.54750287 |
| 58 | response to laminar fluid shear stress (GO:0034616) | 3.51062050 |
| 59 | organic cation transport (GO:0015695) | 3.49409240 |
| 60 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.41564005 |
| 61 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.41564005 |
| 62 | catecholamine transport (GO:0051937) | 3.41251903 |
| 63 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 3.40541654 |
| 64 | regulation of gamma-delta T cell activation (GO:0046643) | 3.40337577 |
| 65 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.39012604 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38800010 |
| 67 | regulation of immunoglobulin production (GO:0002637) | 3.37390046 |
| 68 | regulation of necroptotic process (GO:0060544) | 3.36759294 |
| 69 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.35297046 |
| 70 | response to interferon-beta (GO:0035456) | 3.28914897 |
| 71 | T cell proliferation (GO:0042098) | 3.25838786 |
| 72 | positive regulation of adaptive immune response (GO:0002821) | 3.20840954 |
| 73 | neurotransmitter uptake (GO:0001504) | 3.17439200 |
| 74 | positive regulation of B cell activation (GO:0050871) | 3.15031559 |
| 75 | regulation of T cell cytokine production (GO:0002724) | 3.14766116 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12962256 |
| 77 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.10786599 |
| 78 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.10786599 |
| 79 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.09519006 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.09398847 |
| 81 | cellular response to fluid shear stress (GO:0071498) | 3.09104737 |
| 82 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.08578380 |
| 83 | leukocyte cell-cell adhesion (GO:0007159) | 3.07506882 |
| 84 | regulation of defense response to virus by virus (GO:0050690) | 3.06450033 |
| 85 | cell-cell junction maintenance (GO:0045217) | 3.05924792 |
| 86 | negative thymic T cell selection (GO:0045060) | 3.04751626 |
| 87 | cellular extravasation (GO:0045123) | 3.04204395 |
| 88 | detection of bacterium (GO:0016045) | 3.01980699 |
| 89 | lysosome localization (GO:0032418) | 3.01259494 |
| 90 | detection of other organism (GO:0098543) | 2.99759691 |
| 91 | cellular defense response (GO:0006968) | 2.98608915 |
| 92 | regulation of germinal center formation (GO:0002634) | 2.98060871 |
| 93 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95679626 |
| 94 | negative T cell selection (GO:0043383) | 2.94326948 |
| 95 | negative regulation of necroptotic process (GO:0060546) | 2.92237800 |
| 96 | immunoglobulin mediated immune response (GO:0016064) | 2.90981718 |
| 97 | regulation of hypersensitivity (GO:0002883) | 2.88515257 |
| 98 | T cell activation involved in immune response (GO:0002286) | 2.87088542 |
| 99 | base-excision repair, AP site formation (GO:0006285) | 2.86950318 |
| 100 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86606308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 8.28040766 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.04632467 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.80042200 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.42707424 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07933274 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.05238599 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94341594 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89414963 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87816175 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87175535 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.79980106 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.77335608 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67699141 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67323303 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.44516814 |
| 16 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.42983387 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37601382 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.34936631 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27217984 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18647908 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.15481501 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14170291 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03223107 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.02976392 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02973619 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97323452 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97291361 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97095341 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94467097 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88463312 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87018679 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86427624 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.84564074 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78277834 |
| 35 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.75354572 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.71598958 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67147169 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66077745 |
| 39 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.65741698 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64887529 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60476910 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58233426 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51296435 |
| 44 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.51014580 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48921760 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45895685 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44830383 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40975253 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37949128 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.36097929 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30598225 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27960694 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25237415 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24776178 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22675681 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22098131 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.16500950 |
| 58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.16006380 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15938286 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15518758 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14432561 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13761675 |
| 63 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.11849741 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11228675 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07766662 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05945443 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03779909 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02772156 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02661059 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01797834 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00320207 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98561793 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97745771 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96588186 |
| 75 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96401630 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96229448 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95768738 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94722834 |
| 79 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93832600 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91832540 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90943986 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90407594 |
| 83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89994963 |
| 84 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.89217663 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88975095 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88921299 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88780105 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87828848 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84652947 |
| 90 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.80837860 |
| 91 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80582665 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78879020 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77401370 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76818224 |
| 95 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.76084554 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74422369 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72906776 |
| 98 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.72404746 |
| 99 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71902312 |
| 100 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.71618673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 7.97130380 |
| 2 | MP0002132_abnormal_respiratory_system | 7.70236259 |
| 3 | MP0005671_abnormal_response_to | 4.13500990 |
| 4 | MP0003724_increased_susceptibility_to | 3.38981336 |
| 5 | MP0000858_altered_metastatic_potential | 3.31617462 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.97455628 |
| 7 | MP0001800_abnormal_humoral_immune | 2.92086654 |
| 8 | MP0002405_respiratory_system_inflammati | 2.79854964 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.73601110 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.70257665 |
| 11 | MP0001873_stomach_inflammation | 2.58271787 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.54511681 |
| 13 | MP0003436_decreased_susceptibility_to | 2.53471332 |
| 14 | MP0005408_hypopigmentation | 2.48992076 |
| 15 | MP0010155_abnormal_intestine_physiology | 2.37230869 |
| 16 | MP0009785_altered_susceptibility_to | 2.35491689 |
| 17 | MP0005025_abnormal_response_to | 2.29304311 |
| 18 | MP0002723_abnormal_immune_serum | 2.22781934 |
| 19 | MP0002419_abnormal_innate_immunity | 2.19203030 |
| 20 | MP0004883_abnormal_blood_vessel | 2.09382363 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.05245512 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.05056360 |
| 23 | MP0003828_pulmonary_edema | 2.04745915 |
| 24 | MP0001819_abnormal_immune_cell | 2.04254464 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.01546334 |
| 26 | MP0003690_abnormal_glial_cell | 2.01541466 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.92317412 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.91130311 |
| 29 | MP0001790_abnormal_immune_system | 1.81583292 |
| 30 | MP0005387_immune_system_phenotype | 1.81583292 |
| 31 | MP0000685_abnormal_immune_system | 1.81070962 |
| 32 | MP0002398_abnormal_bone_marrow | 1.67546399 |
| 33 | MP0009697_abnormal_copulation | 1.65728618 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.64900694 |
| 35 | MP0000716_abnormal_immune_system | 1.57651131 |
| 36 | MP0008469_abnormal_protein_level | 1.51924051 |
| 37 | MP0002722_abnormal_immune_system | 1.42535409 |
| 38 | MP0003303_peritoneal_inflammation | 1.40865627 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.34557103 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.31941647 |
| 41 | MP0003866_abnormal_defecation | 1.23928718 |
| 42 | MP0001663_abnormal_digestive_system | 1.20757410 |
| 43 | MP0002429_abnormal_blood_cell | 1.17136685 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.16442162 |
| 45 | MP0005164_abnormal_response_to | 1.15697164 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.14649475 |
| 47 | MP0001851_eye_inflammation | 1.14487416 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.13379688 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.12722811 |
| 50 | MP0004142_abnormal_muscle_tone | 1.11740759 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.08231036 |
| 52 | MP0001915_intracranial_hemorrhage | 1.05016879 |
| 53 | MP0004947_skin_inflammation | 1.04858123 |
| 54 | MP0009764_decreased_sensitivity_to | 1.02602686 |
| 55 | MP0004084_abnormal_cardiac_muscle | 0.97147846 |
| 56 | MP0009278_abnormal_bone_marrow | 0.95772325 |
| 57 | MP0003045_fibrosis | 0.94324280 |
| 58 | MP0004381_abnormal_hair_follicle | 0.91891786 |
| 59 | MP0003183_abnormal_peptide_metabolism | 0.91479430 |
| 60 | MP0003252_abnormal_bile_duct | 0.88888567 |
| 61 | MP0000249_abnormal_blood_vessel | 0.84354054 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 0.82026566 |
| 63 | MP0004036_abnormal_muscle_relaxation | 0.81918224 |
| 64 | MP0002933_joint_inflammation | 0.81258025 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 0.81023446 |
| 66 | MP0001545_abnormal_hematopoietic_system | 0.81023446 |
| 67 | MP0000490_abnormal_crypts_of | 0.79426565 |
| 68 | MP0003638_abnormal_response/metabolism_ | 0.76933096 |
| 69 | MP0005381_digestive/alimentary_phenotyp | 0.74613513 |
| 70 | MP0000920_abnormal_myelination | 0.68107608 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.67995511 |
| 72 | MP0000767_abnormal_smooth_muscle | 0.67823054 |
| 73 | MP0005166_decreased_susceptibility_to | 0.67391636 |
| 74 | MP0005388_respiratory_system_phenotype | 0.66976254 |
| 75 | MP0002133_abnormal_respiratory_system | 0.66976254 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.66679100 |
| 77 | MP0002928_abnormal_bile_duct | 0.65252135 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.63514535 |
| 79 | MP0008873_increased_physiological_sensi | 0.59296494 |
| 80 | MP0009763_increased_sensitivity_to | 0.58998435 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.58632271 |
| 82 | MP0008874_decreased_physiological_sensi | 0.58099029 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.56760521 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.56356110 |
| 85 | MP0002166_altered_tumor_susceptibility | 0.55954362 |
| 86 | MP0004130_abnormal_muscle_cell | 0.52099120 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.51992421 |
| 88 | MP0005647_abnormal_sex_gland | 0.51911130 |
| 89 | MP0003718_maternal_effect | 0.47801911 |
| 90 | MP0008004_abnormal_stomach_pH | 0.47678094 |
| 91 | MP0004510_myositis | 0.46544654 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.45718854 |
| 93 | MP0003448_altered_tumor_morphology | 0.45648007 |
| 94 | MP0001853_heart_inflammation | 0.42047984 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.42044663 |
| 96 | MP0000470_abnormal_stomach_morphology | 0.41849950 |
| 97 | MP0003633_abnormal_nervous_system | 0.41227940 |
| 98 | MP0005595_abnormal_vascular_smooth | 0.38735893 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.38692305 |
| 100 | MP0004808_abnormal_hematopoietic_stem | 0.37665986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 9.81754827 |
| 2 | Abnormality of the nasal mucosa (HP:0000433) | 8.23226204 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 7.05156686 |
| 4 | Zonular cataract (HP:0010920) | 6.74518063 |
| 5 | Myositis (HP:0100614) | 6.45594815 |
| 6 | Abnormality of pyrimidine metabolism (HP:0004353) | 6.37270026 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.24815838 |
| 8 | Abnormality of T cell physiology (HP:0011840) | 5.01495064 |
| 9 | Thrombocytosis (HP:0001894) | 4.79107519 |
| 10 | Abnormality of T cells (HP:0002843) | 4.58466381 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.57119937 |
| 12 | Eczematoid dermatitis (HP:0000976) | 4.49212449 |
| 13 | Hemiplegia (HP:0002301) | 4.11915241 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 4.09326908 |
| 15 | Megaloblastic anemia (HP:0001889) | 4.05678002 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.82288446 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.79936241 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.76402344 |
| 19 | T lymphocytopenia (HP:0005403) | 3.65796813 |
| 20 | Poikilocytosis (HP:0004447) | 3.47686948 |
| 21 | Encephalitis (HP:0002383) | 3.42731509 |
| 22 | Stomatitis (HP:0010280) | 3.38315382 |
| 23 | Spinal muscular atrophy (HP:0007269) | 3.37056789 |
| 24 | Optic neuritis (HP:0100653) | 3.35621548 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.35621548 |
| 26 | Orchitis (HP:0100796) | 3.34528359 |
| 27 | Hypoproteinemia (HP:0003075) | 3.18029623 |
| 28 | Stomach cancer (HP:0012126) | 3.17057738 |
| 29 | Degeneration of anterior horn cells (HP:0002398) | 3.16969801 |
| 30 | Abnormality of the anterior horn cell (HP:0006802) | 3.16969801 |
| 31 | Diaphragmatic weakness (HP:0009113) | 3.14422979 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13042831 |
| 33 | Recurrent fungal infections (HP:0002841) | 3.10557182 |
| 34 | Hypergammaglobulinemia (HP:0010702) | 3.09947525 |
| 35 | Meningitis (HP:0001287) | 3.04140505 |
| 36 | Obstructive sleep apnea (HP:0002870) | 2.93609221 |
| 37 | Hypsarrhythmia (HP:0002521) | 2.93269699 |
| 38 | Stridor (HP:0010307) | 2.85527145 |
| 39 | Pustule (HP:0200039) | 2.82310463 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.81833313 |
| 41 | Increased serum ferritin (HP:0003281) | 2.81699180 |
| 42 | EEG with generalized epileptiform discharges (HP:0011198) | 2.79672299 |
| 43 | Cheilitis (HP:0100825) | 2.75537109 |
| 44 | Increased IgM level (HP:0003496) | 2.72412426 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.68935932 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 2.68850258 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.65120992 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60305121 |
| 49 | Chest pain (HP:0100749) | 2.56457620 |
| 50 | Arterial thrombosis (HP:0004420) | 2.54395771 |
| 51 | Urticaria (HP:0001025) | 2.52924307 |
| 52 | Recurrent skin infections (HP:0001581) | 2.51416368 |
| 53 | Gingival bleeding (HP:0000225) | 2.45089170 |
| 54 | Leukocytosis (HP:0001974) | 2.43410220 |
| 55 | Abnormality of iron homeostasis (HP:0011031) | 2.40473159 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.38032802 |
| 57 | Weak cry (HP:0001612) | 2.36562152 |
| 58 | Facial diplegia (HP:0001349) | 2.35020857 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.34842388 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.34511877 |
| 61 | Eosinophilia (HP:0001880) | 2.34060187 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 2.32153625 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30051466 |
| 64 | Obstructive lung disease (HP:0006536) | 2.30051466 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29768519 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29768519 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.29252389 |
| 68 | Granulocytopenia (HP:0001913) | 2.28182129 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.27069332 |
| 70 | Abnormal platelet function (HP:0011869) | 2.27069332 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.26195915 |
| 72 | Vasculitis (HP:0002633) | 2.23763030 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.22970477 |
| 74 | Erythema (HP:0010783) | 2.21328665 |
| 75 | Epistaxis (HP:0000421) | 2.17761891 |
| 76 | Gingivitis (HP:0000230) | 2.16590320 |
| 77 | Fatigue (HP:0012378) | 2.14666231 |
| 78 | Increased IgE level (HP:0003212) | 2.12029192 |
| 79 | Increased CSF protein (HP:0002922) | 2.11468733 |
| 80 | Parakeratosis (HP:0001036) | 2.10881971 |
| 81 | Hypochromic anemia (HP:0001931) | 2.10250890 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.09773589 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.08703749 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.04705716 |
| 85 | Hemoptysis (HP:0002105) | 2.04147272 |
| 86 | Joint swelling (HP:0001386) | 2.02228813 |
| 87 | Severe combined immunodeficiency (HP:0004430) | 1.96957011 |
| 88 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96830828 |
| 89 | Conjugated hyperbilirubinemia (HP:0002908) | 1.92950392 |
| 90 | Alopecia of scalp (HP:0002293) | 1.92563334 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92248461 |
| 92 | Amaurosis fugax (HP:0100576) | 1.91824544 |
| 93 | Pulmonary infiltrates (HP:0002113) | 1.90714196 |
| 94 | Petechiae (HP:0000967) | 1.90708317 |
| 95 | Chronic diarrhea (HP:0002028) | 1.90172547 |
| 96 | Recurrent bronchitis (HP:0002837) | 1.89299892 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 1.86885770 |
| 98 | 3-Methylglutaconic aciduria (HP:0003535) | 1.86251047 |
| 99 | Recurrent viral infections (HP:0004429) | 1.83298747 |
| 100 | Tetraplegia (HP:0002445) | 1.82754247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ITK | 5.91122596 |
| 2 | ZAP70 | 5.42347847 |
| 3 | PTK2B | 4.32503897 |
| 4 | MAP4K1 | 2.98678636 |
| 5 | RIPK4 | 2.78212828 |
| 6 | FES | 2.53722126 |
| 7 | TXK | 2.44405156 |
| 8 | BTK | 2.37247341 |
| 9 | TBK1 | 2.32920935 |
| 10 | EPHB1 | 2.31082318 |
| 11 | CSK | 2.22545404 |
| 12 | MAPK7 | 2.15702639 |
| 13 | PRKG2 | 2.15278500 |
| 14 | MAP3K12 | 1.98372546 |
| 15 | SYK | 1.94643352 |
| 16 | TGFBR2 | 1.91159269 |
| 17 | MAP3K7 | 1.83366358 |
| 18 | JAK1 | 1.79154498 |
| 19 | PIM1 | 1.72579287 |
| 20 | BLK | 1.71443236 |
| 21 | GRK6 | 1.68597233 |
| 22 | GSK3A | 1.63454239 |
| 23 | IRAK4 | 1.59059789 |
| 24 | CDK4 | 1.52804690 |
| 25 | TNK2 | 1.51255166 |
| 26 | JAK3 | 1.47259117 |
| 27 | STK39 | 1.41613840 |
| 28 | HCK | 1.41476424 |
| 29 | PDGFRB | 1.37130590 |
| 30 | WNK4 | 1.36755702 |
| 31 | PRPF4B | 1.35639597 |
| 32 | MAP2K3 | 1.25826454 |
| 33 | TAOK3 | 1.25718611 |
| 34 | STK10 | 1.23262210 |
| 35 | LCK | 1.22487170 |
| 36 | CDK3 | 1.19595894 |
| 37 | TYK2 | 1.18279752 |
| 38 | PAK4 | 1.17224450 |
| 39 | LYN | 1.14020132 |
| 40 | TESK2 | 1.12546001 |
| 41 | GRK7 | 1.10158653 |
| 42 | ERN1 | 1.06548289 |
| 43 | TEC | 0.96583612 |
| 44 | TAOK1 | 0.94864834 |
| 45 | MYLK | 0.92445521 |
| 46 | MAP3K3 | 0.87855913 |
| 47 | PIK3CG | 0.80142959 |
| 48 | CHEK2 | 0.78821519 |
| 49 | FGR | 0.76473469 |
| 50 | STK38 | 0.75654006 |
| 51 | JAK2 | 0.74054178 |
| 52 | PDK1 | 0.73171274 |
| 53 | PRKCZ | 0.72349506 |
| 54 | LRRK2 | 0.65727625 |
| 55 | FYN | 0.65487103 |
| 56 | IKBKE | 0.65026228 |
| 57 | MARK3 | 0.63047397 |
| 58 | KDR | 0.62855400 |
| 59 | KIT | 0.62774961 |
| 60 | PTK6 | 0.61352777 |
| 61 | BMPR2 | 0.56870710 |
| 62 | MOS | 0.56743617 |
| 63 | PRKCQ | 0.55964335 |
| 64 | SIK3 | 0.55499893 |
| 65 | ILK | 0.55061351 |
| 66 | WNK1 | 0.54231405 |
| 67 | MAP3K14 | 0.53309846 |
| 68 | CSF1R | 0.50220901 |
| 69 | MAP2K6 | 0.48881177 |
| 70 | YES1 | 0.47669338 |
| 71 | GRK5 | 0.47147181 |
| 72 | INSR | 0.46981317 |
| 73 | MAP3K11 | 0.45206303 |
| 74 | MARK2 | 0.42577395 |
| 75 | PRKCH | 0.40902907 |
| 76 | IKBKB | 0.35658921 |
| 77 | DAPK1 | 0.35177158 |
| 78 | PRKAA2 | 0.34781148 |
| 79 | PIK3CA | 0.34186459 |
| 80 | MAPK12 | 0.33799473 |
| 81 | PDPK1 | 0.33216192 |
| 82 | IGF1R | 0.32730051 |
| 83 | FRK | 0.32666627 |
| 84 | FER | 0.30428365 |
| 85 | MAP3K1 | 0.29995484 |
| 86 | MATK | 0.29004509 |
| 87 | CSNK1A1 | 0.29002208 |
| 88 | PRKACG | 0.27713538 |
| 89 | EPHA3 | 0.27322948 |
| 90 | PKN1 | 0.24657753 |
| 91 | SIK2 | 0.24434520 |
| 92 | TAOK2 | 0.23788270 |
| 93 | RET | 0.22845978 |
| 94 | STK4 | 0.22376749 |
| 95 | ADRBK1 | 0.20029439 |
| 96 | PRKD2 | 0.19323057 |
| 97 | IRAK1 | 0.19128631 |
| 98 | SGK3 | 0.19063059 |
| 99 | CAMKK2 | 0.18778760 |
| 100 | PRKCE | 0.18677185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.26732848 |
| 2 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.14583168 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.02953365 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91535872 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.90759345 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.76536984 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.61324651 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.40567423 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.39293098 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36466864 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.33740792 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.30306085 |
| 13 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.28017137 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22676760 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.21004887 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95714419 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74162956 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68787224 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.66423027 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60239317 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58755014 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43431017 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40166862 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38198441 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37264744 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34180639 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33367646 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33195896 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28314459 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.28150958 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.26074043 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24555486 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06725816 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06152810 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05571829 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05402801 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04395127 |
| 38 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99382650 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98250328 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96371024 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96172717 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.91388709 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 0.90285466 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90119125 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.85798052 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84605039 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83412015 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.81937698 |
| 49 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76230402 |
| 50 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74079312 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71795779 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.71737517 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70803398 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70669135 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.69814428 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67932946 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.65469906 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.60652579 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60112091 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57970097 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57896472 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57415269 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.57270281 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56134478 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55237091 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.52346158 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50315610 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48991622 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48511232 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47790960 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47787792 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.47572836 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47310817 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47148552 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46618287 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.44435930 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.43685996 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40282024 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40065252 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38626171 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38043634 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37766281 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36104118 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34789331 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34701141 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34199375 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.33901456 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33585487 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28614689 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27197813 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.25355918 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24450858 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.21063448 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.20942742 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.20143292 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19351110 |
| 97 | Base excision repair_Homo sapiens_hsa03410 | 0.19347779 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19048063 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18362026 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18177496 |

